D
ecreased mobility is one of the most common reasons for admission to a rehabilitation unit. A significant dosage of repetitive task-specific practice is provided to maximize walking abilities among patients in a rehabilitation unit. [1] [2] [3] [4] Knowing the amount of exercise that each patient completes in the rehabilitation setting assists therapists' intervention decisions and review of patients' goal achievement. Accurate feedback about exercise dosage and subsequent improvement are likely to be motivating factors for patients. 5 Therefore, accurate recording of the dosage of exercise that participants complete has significant clinical implications. 6 While time spent in therapy has been the most common measure of exercise dosage, dosage of practice performed in a fixed time period has been shown to be highly variable between patients. 7 Counting each repetition of exercise a patient completes is a more reliable record of exercise dosage, as it does not include rest time. Several published studies have used repetitions to accurately measure the actual dosage each rehabilitation patient completes. 3, [8] [9] [10] [11] [12] Counting the number of steps taken during walking practice can be considered an objective measure of the amount of mobility training a patient has completed. Encouraging individuals in the community to reach a certain number of steps each day is a common strategy used in the community to promote improved health.
Visually counting the number of steps patients take during their therapy would be labor intensive and unlikely to count steps taken outside of therapy time. Fortunately, there are many activity monitors currently available that can be used to count steps. Different activity monitors have advantages and disadvantages, including cost, comfort, ease of use, and immediacy of feedback provided. Some monitors are likely to be more suited for research and others for clinical purposes such as motivation.
A number of commonly used activity monitors have been found to accurately count steps in active populations of younger [13] [14] [15] [16] and older people. [17] [18] [19] Several studies [20] [21] [22] [23] have identified the need for further validation of activity monitors in slower walking populations. No studies have compared the accuracy of multiple activity monitors in a very slow walking population, as is often seen in an inpatient rehabilitation setting. There is currently no information to guide which activity monitors accurately measure step counts in people who walk slowly. Nor has the optimal placement of the monitors been determined or whether monitor accuracy is influenced by specific gait parameters or the use of walking aids.
Our research questions were:
1. What is the validity of activity monitors for measuring step counts in rehabilitation inpatients compared with visually observed step counts?
2. Do specific gait parameters influence the accuracy of these activity monitors?
3. Does the position of the monitor influence its accuracy?
4. Does the use of a walker influence activity monitor accuracy?
Methods

Participants
Patients were recruited from the General Rehabilitation and Stroke Rehabilitation Units at Bankstown-Lidcombe Hospital, Sydney, Australia. All patients on these wards were screened weekly for study eligibility, and those meeting the eligibility criteria were invited to participate. Participants were eligible if they (1) had a gait speed <1.2 m/s or an observable gait abnormality thought by their physical therapist as likely to impact the accuracy of the activity monitor; (2) were able to walk at least 10 meters (m) with or without a gait aid or with or without assistance of one person; and (3) were medically stable to participate in a 6-Minute Walk Test (6MWT An assessor (D.T., a senior physical therapist with >10 years experience in rehabilitation) concurrently counted the steps each individual took using a hand-held counter. This is referred to as the observed step count. To determine the reliability of the observed step count, a second assessor simultaneously counted the number of steps taken by 17 (10%) participants using a handheld counter. The second assessors included physiotherapy students, physiotherapy assistants, junior and senior physiotherapy staff, and physiotherapy research staff. Interrater reliability between observed step counts by the 2 assessors was excellent, with an intraclass correlation coefficient (ICC 2,1 ) of 0.999 (95% CI: 0.987-1.000). The percentage agreement between the 2 observed step counts was 99.0% (SD 0.8%).
Participants then performed 2 walking trials along a 14-foot GAITRite Gold walkway (CIR Systems Inc, New York). GAITRite is a portable gait analysis system embedded with pressure sensors that detect footfalls as the participant walks the length of the mat. The software enables the measurement of multiple gait parameters, including walking speed, cadence, step length, and duration of swing and stance phases. GAITRite has been shown to be highly reliable in measuring most gait parameters. 24 The GaitRite Gold walkway contained half inch square sensors that were laid out in 2 × 2 feet pads. The walkway had 7 pads, for a total of 16 128 sensors covering an active area 2 feet wide and 14 feet long. The walkway had a sampling frequency of 16.614 msec. Participants started walking 1 m before and finished 1 m beyond the gait mat. Participants sat down on a chair after each trial to rest. Participants were asked to walk at their normal speeds for each test. The assessor counted the number of steps as per the process for the 6MWT test.
For both walking tests participants walked unaided or used their current gait aid. The assessor walked slightly behind and to the side of the participant so as not to influence the participant's walking speed.
Data Analysis
Data were analyzed using Stata v13 (StataCorp LP, College Station, Texas). ICC 2,1 were used to examine criterion validity between step counts taken from each of the devices compared with the observed step count during the 6MWT. An ICC ≥0.75 was considered excellent, 0.60-0.74 good, 0.40-0.59 fair, and <0.40 poor. 25 The most accurate step count between the left and right sides (ie, the step count closest to the observed step count) was used for the primary analysis of each device at each body position. The percentage agreement for each device compared with the observed step count was calculated as: (activity monitor measured step count / observed step count) × 100. The accuracy within a close agreement (within 6 steps of the observed step count) and within 10% and 20% agreement was assessed for each activity monitor.
Average absolute error was calculated as the difference between the activity monitor count and the observed step count for each activity monitor. The percentage of occasions that each device did not record any steps taken was recorded.
The influence of different gait parameters on the percentage agreement between measured and observed step count was visually assessed by graphing the percentage agreement for each activity monitor against the following gait parameters assessed by the GAITRite: walking speed, cadence, stride length, swing speed, double support stance phase percentage, and gait variability.
Subgroup analyses were performed on participants with a unilateral physical impairment and comparing those using and not using a walker. ICC 2,1 and percentage agreements were used to examine agreements between step counts taken from each device compared with the observed step count on both the affected side and the unaffected side. The effect of using a walker on device accuracy was assessed by graphing the percentage agreement of the observed step count for each device against walking speed for individuals who did and did not use a walker.
Results
During the recruitment period, 402 patients were admitted to the 2 rehabilitation wards at Bankstown-Lidcombe Hospital. One hundred and sixty-six of these individuals participated. Of the 236 patients who did not participate, 39 were ineligible because they were unable to walk 10 m despite the assistance of one person and/or a walker, and 187 participants declined to participate in the study. The majority of participants were male with slower than normal walking speeds admitted for rehabilitation with a mix of musculoskeletal and neurological health conditions (Table 1) . Data were collected from all 16 devices for all participants except for one participant who had data collected from only 14 devices due to a previous left upper limb amputation (no data were collected from the Garmin Vivofit and Fitbit Charge, both located on the left wrist). (Table 2 ).
Concurrent Validity and Accuracy Compared with Observed Step Count
There were no occasions where the StepWatch did not record any steps on either side. The Garmin Vivofit did not record any of the steps taken during the 6MWT on 49% of participants. There were a few occasions where the ActivPAL (0.6%) and the Actigraph (2.4%) did not record any steps taken on either side ( Table 2 ). The Actigraph showed the highest absolute error during the 6MWT (299 steps per participant), followed by the Garmin Vivofit (269), G-Sensor (233), Fitbit One worn on the hip (201), and Fitbit Charge (182).
Influence of Gait Parameters on Accuracy of Activity Monitors
For participants who walked with a walking speed between 0.8 to 1.2 m/s, all devices except the Actigraph showed ≥90% agreement with the observed step count (Figure 1 ). Accuracy of all devices decreased as walking speed decreased. The StepWatch maintained close to 100% accuracy with the observed step count at all speeds except below 0.2 For participants who walked with a stride length longer than 1.0 m, all devices except the Actigraph showed ≥90% agreement with the observed step count (Figure 2) . The accuracy of all devices decreased with decreasing stride length. The StepWatch maintained close to 100% agreement with the observed step count at all stride lengths except those <0.4 m, when its accuracy decreased to 89%.
The speed of the swinging leg appeared to influence the accuracy of the StepWatch, ActivPAL, and the Fitbit One worn on the ankle. The accuracy of these devices (online supplement 2: Leg swing velocity vs percentage accuracy of the observed step count) decreased as leg swing speed decreased. Cadence, double support stance phase percentage, and gait variability did not appear to have a strong influence on the accuracy of these devices (online supplement 3: Alternate gait parameters versus percentage accuracy of the observed step count). Table 3 compares the accuracy of each device when worn on the unaffected side compared with the affected side for participants with a unilateral physical impairment (n = 100). For the StepWatch, ActivPAL, and Fitbit One worn on the ankle, wearing the device on the unaffected side on average resulted in greater accuracy than wearing the device on the affected side. However, there were occasions when the affected side had greater accuracy than the unaffected side. For all other devices, there was no difference in accuracy when wearing the device on the unaffected or affected side.
Location of Activity Monitor and Use of Walkers on Accuracy of Activity Monitor
The accuracy of the leg-worn devices was similar for those who used (n = 87) and did not use (n = 79) a walker (online supplement 4: Alternate graphs walker versus no walker), but the accuracy of the wrist-worn devices (Garmin Vivofit and Fitbit Charge) was worse at slower speeds among walker users ( Figure 3 ). Between speeds of 0.2 m/s and 0.8 m/s, the monitors were less accurate for those who used a walker. At speeds below 0.2 m/s, the accuracy of the devices was very poor regardless of walker use.
Discussion
At walking speeds between 0.8 and 1.2 m/s, all devices except the Actigraph showed high accuracy, and the choice of device at these speeds should be determined by the purpose of using the device, patient preference, and features of the device such as those described in the eTable (available at academic.oup.com/ptj)-for instance, cost, charging requirements, parameters reported. At these speeds, the use of a walker may not affect the accuracy of these devices. However, at slower speeds and shorter step lengths the accuracy of these devices varies considerably. Additionally the use of a walker and/or the side on which the device is attached can affect accuracy. The StepWatch showed the highest accuracy and closest agreement with the observed step count of all the devices across all gait parameters for individuals assessed in this study.
The 3 devices with the strongest agreement (the StepWatch, Fitbit One worn on the ankle, and ActivPAL) were the ones worn lower down the leg. These results are similar to findings by Klassen et al, 26 who found that placement of the Fitbit One at the ankle was more accurate than at the waist in slow walking community-dwelling survivors of stroke. All devices use an accelerometer to detect motion and attempt to distinguish steps from other activity. Each device has a threshold for this acceleration signal to determine whether the motion detected represents a step. The slower swing-through of the leg in slower walking individuals may mean that acceleration at the hip may not be sufficient to detect a step, whereas acceleration at the thigh and ankle is greater, thus the device is more likely to detect steps.
For the 3 most accurate devices (the StepWatch, the Fitbit One worn on the ankle, and the ActivPAL), wearing them on the unaffected side appeared more accurate; however, there were occasions when this was not the case. For individuals with bilaterally affected sides, it is not always possible to predict which side will be the most accurate. Therefore, it is recommended that the chosen activity monitor be trialed initially on both sides and compared with a manual count to identify which side is most accurate for that individual.
A key reason for using activity monitors in clinical settings is to provide feedback to patients to aid motivation to improve mobility. The high percentage of recorded zeroes for the Garmin Vivofit, Fitbit Charge, and Fitbit One Gait velocity (m/s) from GAITRite versus percentage accuracy of the observed step count for patients either using a walker or not using a walker when using a wrist-worn activity monitor.
worn on the hip is likely to be a significant problem if these devices are being used for motivation. Fortunately the Fitbit One worn on the ankle showed the highest accuracy of all the devices that provided immediate feedback. However, the ability of this population to use this feedback to improve mobility requires further investigation. This study did not investigate other factors such as comfort, usability, or participant preference. Future qualitative research may provide insight into these issues.
The main limitation of the study is the small number of participants for some gait parameters. There were only 2 participants who walked with a stride length >1.2 m and only 1 participant who walked with a walker at a speed >0.8 m/s, making it difficult to determine the accuracy of these activity monitors for those parameters.
This study is the first to compare multiple devices on participants walking with slow to very slow walking speeds in an inpatient rehabilitation setting. It is the only study to date to examine the influence of a range of gait parameters on the accuracy of multiple devices in a very slow walking population. The StepWatch showed the highest accuracy and closest agreement with the observed step count of the 7 devices assessed in this study and can be used by researchers for accurate measurement of the number of steps taken in this population. However, the StepWatch does not provide immediate feedback. The next most accurate device was the Fitbit One when worn on the ankle, and this device can provide immediate feedback about step counts. This may be of benefit for patients and therapists in a rehabilitation setting who require immediate objective measures and feedback of the amount of activity. 
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